Sue Gail Eckhardt - 14 Feb 2025 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Reporting relationship: Director
Issuer ticker: EXEL
Reported as of: 14 Feb 2025
Net transaction value: -$225,884
SEC form: 4
Accepted by SEC: 19 Feb 2025, 20:31:05 UTC
Prior SEC filing: 07 Jun 2024
Next SEC filing: 30 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Nina Ayer, Attorney in Fact

Key filing fact

Sue Gail Eckhardt filed Form 4 for EXELIXIS, INC. (EXEL) on 19 Feb 2025.

Key facts

This page summarizes Sue Gail Eckhardt's Form 4 filing for EXELIXIS, INC. (EXEL).
4 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 19 Feb 2025, 20:31.

Change

Previous filing in this sequence was filed on 07 Jun 2024.
Current net transaction value: -$225,884.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EXEL transaction

Common Stock

Options Exercise

Transaction value: $179,227
Shares: +7,712
Change %: +23%
Price: $23.24
Shares after: 41,974
Date: 14 Feb 2025
Ownership: Direct
Footnotes: F1

EXEL transaction

Common Stock

Sale

Transaction value: $269,997
Shares: -7,712
Change %: -18%
Price: $35.01
Shares after: 34,262
Date: 14 Feb 2025
Ownership: Direct
Footnotes: F1, F2

EXEL transaction

Common Stock

Sale

Transaction value: $135,114
Shares: -3,856
Change %: -11%
Price: $35.04
Shares after: 30,406
Date: 14 Feb 2025
Ownership: Direct
Footnotes: F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EXEL transaction Derivative

Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -7,712
Change %: -25%
Price: $0.000000
Shares after: 23,136
Date: 14 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,712
Exercise price: $23.24
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

Includes 30,406 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.

Footnote F2

Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $34.37 to $35.23. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.

Footnote F3

Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $34.95 to $35.20. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.

Footnote F4

The option, representing the right to purchase a total of 30,848 shares of Common Stock, became fully exercisable on January 5, 2024.